Dideoxy fluoro-ketopyranosyl nucleosides as potent antiviral agents: Synthesis and biological evaluation of 2,3- and 3,4-dideoxy-3-fluoro-4-and -2-keto-β-D-glucopyranosyl derivatives of N4-benzoyl cytosine

The synthesis of the dideoxy fluoro ketopyranonucleoside analogues, 1-(2,3-dideoxy-3-fluoro-6- O -trityl-β- d -glycero-hexopyranosyl-4-ulose)- N 4 -benzoyl cytosine ( 7a ), 1-(3,4-dideoxy-3-fluoro-6- O -trityl-β- d -glycero-hexopyranosyl-2-ulose)- N 4 -benzoyl cytosine ( 13a ) and their detritylated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of medicinal chemistry 2009-06, Vol.44 (6), p.2696-2704
Hauptverfasser: MANTA, Stella, TSOUKALA, Evangelia, TZIOUMAKI, Niki, GOROPEVSEK, Ales, PAMULAPATI, Ravi Teja, CENCIC, Avrelija, BALZARINI, Jan, KOMIOTIS, Dimitri
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2704
container_issue 6
container_start_page 2696
container_title European journal of medicinal chemistry
container_volume 44
creator MANTA, Stella
TSOUKALA, Evangelia
TZIOUMAKI, Niki
GOROPEVSEK, Ales
PAMULAPATI, Ravi Teja
CENCIC, Avrelija
BALZARINI, Jan
KOMIOTIS, Dimitri
description The synthesis of the dideoxy fluoro ketopyranonucleoside analogues, 1-(2,3-dideoxy-3-fluoro-6- O -trityl-β- d -glycero-hexopyranosyl-4-ulose)- N 4 -benzoyl cytosine ( 7a ), 1-(3,4-dideoxy-3-fluoro-6- O -trityl-β- d -glycero-hexopyranosyl-2-ulose)- N 4 -benzoyl cytosine ( 13a ) and their detritylated analogues 8a and 14a , respectively, is described. Condensation of peracetylated 3-deoxy-3-fluoro- d -glucopyranose ( 1 ) with silylated N 4 -benzoyl cytosine, followed by selective deprotection and isopropylidenation afforded compound 2 . Routine deoxygenation at position 2′, followed by a deprotection-selective reprotection sequence afforded the partially tritylated dideoxy nucleoside of cytosine 6 , which upon oxidation of the free hydroxyl group at the 4′-position, furnished the desired tritylated 2,3-dideoxy-3-fluoro ketonucleoside 7a in equilibrium with its hydrated form 7b . Compound 2 was the starting material for the synthesis of the dideoxy fluoro ketopyranonucleoside 13a . Similarly, several subsequent protection and deprotection steps as well as routine deoxygenation at position 4′, followed by oxidation of the free hydroxyl group at the 2′-position of the partially tritylated dideoxy nucleoside 12 , yielded the desired carbonyl compound 13a in equilibrium with its hydrated form 13b . Finally, trityl removal from 7a / b and 13a / b provided the unprotected 2,3-dideoxy-3-fluoro-4-keto and 3,4-dideoxy-3-fluoro-2-ketopyranonucleoside analogues 8a and 14a , in equilibrium with their gem-diol forms 8b and 14b . None of the compounds showed inhibitory activity against a wide variety of DNA and RNA viruses at subtoxic concentrations, except 7a / b that was highly efficient against rotavirus infection. Nucleoside 7a / b also exhibited cytostatic activity against cells of various cancers. BrdU-cell cycle analysis revealed that the mechanism of cytostatic activity may be related to a delay in G1/S phase and initiation of programmed cell death. A synthesis of the novel dideoxy fluoro ketopyranonucleoside analogues of N 4 -benzoyl cytosine ( 7a , 8a and 13a , 14a ) in equilibrium with their hydrated forms ( 7b , 8b and 13b , 14b ) is reported. 7a / b was highly efficient against rotavirus infection and exhibited high and selective antitumor activity against cells of various cancers as compared with other compounds, AZT or 5FU respectively. BrdU-cell cycle analysis revealed that the mechanism of antitumor activity may be related to a delay in G1/S phase and prog
doi_str_mv 10.1016/j.ejmech.2009.01.020
format Article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7126854</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_7126854</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2270-aac9a8b51c6aa824a3aa858d42ad6a1ad47d237e1a5aedbfb81c691be5882843</originalsourceid><addsrcrecordid>eNpVUctu2zAQJIoUjZv2D3rgJbdQ5UsSnUOAIOkLCNpDcydWJGXTkUlDlIQon9UPyTeVjo2gPS0WOzM7mEHoE6MFo6z6vCncZuvMuuCULgvKCsrpG7RgdaWI4KU8QQvKuSAlF_IUvU9pQyktK0rfoVO25LJigi7Q8623Lj7OuO3G2Efy4Ia4m3sIMc0dDqPpXEwZkjAkvIuDCwOGMPjJ99BhWOU9XeLfcxjWLvmMChY3PnZx5U0GuAm6EQYfA44t5heCvCDEhST28JgIcnwtyf5E-IsH8vyH3JJVN5p_7FjX-ymrTdlOlvspSePCU8wXMw_ZZnAf0NsWuuQ-HucZuv_65f7mO7n79e3HzfUdMZzXlACYJaimZKYCUFyCyKNUVnKwFTCwsrZc1I5BCc42baMycskaVyrFlRRn6OoguxubrbMmp5Dj0Lveb6GfdQSv_78Ev9arOOma8UqVewF5EDB9TKl37SuXUb2vV2_0oV69r1dTpnO9mXZ-_Aspx9vmYIxPr1zOpKpz_-IvQeCtMw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Dideoxy fluoro-ketopyranosyl nucleosides as potent antiviral agents: Synthesis and biological evaluation of 2,3- and 3,4-dideoxy-3-fluoro-4-and -2-keto-β-D-glucopyranosyl derivatives of N4-benzoyl cytosine</title><source>Elsevier ScienceDirect Journals</source><creator>MANTA, Stella ; TSOUKALA, Evangelia ; TZIOUMAKI, Niki ; GOROPEVSEK, Ales ; PAMULAPATI, Ravi Teja ; CENCIC, Avrelija ; BALZARINI, Jan ; KOMIOTIS, Dimitri</creator><creatorcontrib>MANTA, Stella ; TSOUKALA, Evangelia ; TZIOUMAKI, Niki ; GOROPEVSEK, Ales ; PAMULAPATI, Ravi Teja ; CENCIC, Avrelija ; BALZARINI, Jan ; KOMIOTIS, Dimitri</creatorcontrib><description>The synthesis of the dideoxy fluoro ketopyranonucleoside analogues, 1-(2,3-dideoxy-3-fluoro-6- O -trityl-β- d -glycero-hexopyranosyl-4-ulose)- N 4 -benzoyl cytosine ( 7a ), 1-(3,4-dideoxy-3-fluoro-6- O -trityl-β- d -glycero-hexopyranosyl-2-ulose)- N 4 -benzoyl cytosine ( 13a ) and their detritylated analogues 8a and 14a , respectively, is described. Condensation of peracetylated 3-deoxy-3-fluoro- d -glucopyranose ( 1 ) with silylated N 4 -benzoyl cytosine, followed by selective deprotection and isopropylidenation afforded compound 2 . Routine deoxygenation at position 2′, followed by a deprotection-selective reprotection sequence afforded the partially tritylated dideoxy nucleoside of cytosine 6 , which upon oxidation of the free hydroxyl group at the 4′-position, furnished the desired tritylated 2,3-dideoxy-3-fluoro ketonucleoside 7a in equilibrium with its hydrated form 7b . Compound 2 was the starting material for the synthesis of the dideoxy fluoro ketopyranonucleoside 13a . Similarly, several subsequent protection and deprotection steps as well as routine deoxygenation at position 4′, followed by oxidation of the free hydroxyl group at the 2′-position of the partially tritylated dideoxy nucleoside 12 , yielded the desired carbonyl compound 13a in equilibrium with its hydrated form 13b . Finally, trityl removal from 7a / b and 13a / b provided the unprotected 2,3-dideoxy-3-fluoro-4-keto and 3,4-dideoxy-3-fluoro-2-ketopyranonucleoside analogues 8a and 14a , in equilibrium with their gem-diol forms 8b and 14b . None of the compounds showed inhibitory activity against a wide variety of DNA and RNA viruses at subtoxic concentrations, except 7a / b that was highly efficient against rotavirus infection. Nucleoside 7a / b also exhibited cytostatic activity against cells of various cancers. BrdU-cell cycle analysis revealed that the mechanism of cytostatic activity may be related to a delay in G1/S phase and initiation of programmed cell death. A synthesis of the novel dideoxy fluoro ketopyranonucleoside analogues of N 4 -benzoyl cytosine ( 7a , 8a and 13a , 14a ) in equilibrium with their hydrated forms ( 7b , 8b and 13b , 14b ) is reported. 7a / b was highly efficient against rotavirus infection and exhibited high and selective antitumor activity against cells of various cancers as compared with other compounds, AZT or 5FU respectively. BrdU-cell cycle analysis revealed that the mechanism of antitumor activity may be related to a delay in G1/S phase and programmed cell death initiation.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2009.01.020</identifier><identifier>PMID: 19246130</identifier><identifier>CODEN: EJMCA5</identifier><language>eng</language><publisher>Kidlington: Elsevier</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antineoplastic agents ; Antiviral agents ; Biological and medical sciences ; General aspects ; Medical sciences ; Pharmacology. Drug treatments ; Short Communication</subject><ispartof>European journal of medicinal chemistry, 2009-06, Vol.44 (6), p.2696-2704</ispartof><rights>2009 INIST-CNRS</rights><rights>Copyright © 2009 Elsevier Masson SAS. All rights reserved. 2009 Elsevier Masson SAS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2270-aac9a8b51c6aa824a3aa858d42ad6a1ad47d237e1a5aedbfb81c691be5882843</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21487768$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>MANTA, Stella</creatorcontrib><creatorcontrib>TSOUKALA, Evangelia</creatorcontrib><creatorcontrib>TZIOUMAKI, Niki</creatorcontrib><creatorcontrib>GOROPEVSEK, Ales</creatorcontrib><creatorcontrib>PAMULAPATI, Ravi Teja</creatorcontrib><creatorcontrib>CENCIC, Avrelija</creatorcontrib><creatorcontrib>BALZARINI, Jan</creatorcontrib><creatorcontrib>KOMIOTIS, Dimitri</creatorcontrib><title>Dideoxy fluoro-ketopyranosyl nucleosides as potent antiviral agents: Synthesis and biological evaluation of 2,3- and 3,4-dideoxy-3-fluoro-4-and -2-keto-β-D-glucopyranosyl derivatives of N4-benzoyl cytosine</title><title>European journal of medicinal chemistry</title><description>The synthesis of the dideoxy fluoro ketopyranonucleoside analogues, 1-(2,3-dideoxy-3-fluoro-6- O -trityl-β- d -glycero-hexopyranosyl-4-ulose)- N 4 -benzoyl cytosine ( 7a ), 1-(3,4-dideoxy-3-fluoro-6- O -trityl-β- d -glycero-hexopyranosyl-2-ulose)- N 4 -benzoyl cytosine ( 13a ) and their detritylated analogues 8a and 14a , respectively, is described. Condensation of peracetylated 3-deoxy-3-fluoro- d -glucopyranose ( 1 ) with silylated N 4 -benzoyl cytosine, followed by selective deprotection and isopropylidenation afforded compound 2 . Routine deoxygenation at position 2′, followed by a deprotection-selective reprotection sequence afforded the partially tritylated dideoxy nucleoside of cytosine 6 , which upon oxidation of the free hydroxyl group at the 4′-position, furnished the desired tritylated 2,3-dideoxy-3-fluoro ketonucleoside 7a in equilibrium with its hydrated form 7b . Compound 2 was the starting material for the synthesis of the dideoxy fluoro ketopyranonucleoside 13a . Similarly, several subsequent protection and deprotection steps as well as routine deoxygenation at position 4′, followed by oxidation of the free hydroxyl group at the 2′-position of the partially tritylated dideoxy nucleoside 12 , yielded the desired carbonyl compound 13a in equilibrium with its hydrated form 13b . Finally, trityl removal from 7a / b and 13a / b provided the unprotected 2,3-dideoxy-3-fluoro-4-keto and 3,4-dideoxy-3-fluoro-2-ketopyranonucleoside analogues 8a and 14a , in equilibrium with their gem-diol forms 8b and 14b . None of the compounds showed inhibitory activity against a wide variety of DNA and RNA viruses at subtoxic concentrations, except 7a / b that was highly efficient against rotavirus infection. Nucleoside 7a / b also exhibited cytostatic activity against cells of various cancers. BrdU-cell cycle analysis revealed that the mechanism of cytostatic activity may be related to a delay in G1/S phase and initiation of programmed cell death. A synthesis of the novel dideoxy fluoro ketopyranonucleoside analogues of N 4 -benzoyl cytosine ( 7a , 8a and 13a , 14a ) in equilibrium with their hydrated forms ( 7b , 8b and 13b , 14b ) is reported. 7a / b was highly efficient against rotavirus infection and exhibited high and selective antitumor activity against cells of various cancers as compared with other compounds, AZT or 5FU respectively. BrdU-cell cycle analysis revealed that the mechanism of antitumor activity may be related to a delay in G1/S phase and programmed cell death initiation.</description><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antineoplastic agents</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>General aspects</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Short Communication</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNpVUctu2zAQJIoUjZv2D3rgJbdQ5UsSnUOAIOkLCNpDcydWJGXTkUlDlIQon9UPyTeVjo2gPS0WOzM7mEHoE6MFo6z6vCncZuvMuuCULgvKCsrpG7RgdaWI4KU8QQvKuSAlF_IUvU9pQyktK0rfoVO25LJigi7Q8623Lj7OuO3G2Efy4Ia4m3sIMc0dDqPpXEwZkjAkvIuDCwOGMPjJ99BhWOU9XeLfcxjWLvmMChY3PnZx5U0GuAm6EQYfA44t5heCvCDEhST28JgIcnwtyf5E-IsH8vyH3JJVN5p_7FjX-ymrTdlOlvspSePCU8wXMw_ZZnAf0NsWuuQ-HucZuv_65f7mO7n79e3HzfUdMZzXlACYJaimZKYCUFyCyKNUVnKwFTCwsrZc1I5BCc42baMycskaVyrFlRRn6OoguxubrbMmp5Dj0Lveb6GfdQSv_78Ev9arOOma8UqVewF5EDB9TKl37SuXUb2vV2_0oV69r1dTpnO9mXZ-_Aspx9vmYIxPr1zOpKpz_-IvQeCtMw</recordid><startdate>200906</startdate><enddate>200906</enddate><creator>MANTA, Stella</creator><creator>TSOUKALA, Evangelia</creator><creator>TZIOUMAKI, Niki</creator><creator>GOROPEVSEK, Ales</creator><creator>PAMULAPATI, Ravi Teja</creator><creator>CENCIC, Avrelija</creator><creator>BALZARINI, Jan</creator><creator>KOMIOTIS, Dimitri</creator><general>Elsevier</general><general>Elsevier Masson SAS</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>200906</creationdate><title>Dideoxy fluoro-ketopyranosyl nucleosides as potent antiviral agents: Synthesis and biological evaluation of 2,3- and 3,4-dideoxy-3-fluoro-4-and -2-keto-β-D-glucopyranosyl derivatives of N4-benzoyl cytosine</title><author>MANTA, Stella ; TSOUKALA, Evangelia ; TZIOUMAKI, Niki ; GOROPEVSEK, Ales ; PAMULAPATI, Ravi Teja ; CENCIC, Avrelija ; BALZARINI, Jan ; KOMIOTIS, Dimitri</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2270-aac9a8b51c6aa824a3aa858d42ad6a1ad47d237e1a5aedbfb81c691be5882843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antineoplastic agents</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>General aspects</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Short Communication</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MANTA, Stella</creatorcontrib><creatorcontrib>TSOUKALA, Evangelia</creatorcontrib><creatorcontrib>TZIOUMAKI, Niki</creatorcontrib><creatorcontrib>GOROPEVSEK, Ales</creatorcontrib><creatorcontrib>PAMULAPATI, Ravi Teja</creatorcontrib><creatorcontrib>CENCIC, Avrelija</creatorcontrib><creatorcontrib>BALZARINI, Jan</creatorcontrib><creatorcontrib>KOMIOTIS, Dimitri</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MANTA, Stella</au><au>TSOUKALA, Evangelia</au><au>TZIOUMAKI, Niki</au><au>GOROPEVSEK, Ales</au><au>PAMULAPATI, Ravi Teja</au><au>CENCIC, Avrelija</au><au>BALZARINI, Jan</au><au>KOMIOTIS, Dimitri</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dideoxy fluoro-ketopyranosyl nucleosides as potent antiviral agents: Synthesis and biological evaluation of 2,3- and 3,4-dideoxy-3-fluoro-4-and -2-keto-β-D-glucopyranosyl derivatives of N4-benzoyl cytosine</atitle><jtitle>European journal of medicinal chemistry</jtitle><date>2009-06</date><risdate>2009</risdate><volume>44</volume><issue>6</issue><spage>2696</spage><epage>2704</epage><pages>2696-2704</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><coden>EJMCA5</coden><abstract>The synthesis of the dideoxy fluoro ketopyranonucleoside analogues, 1-(2,3-dideoxy-3-fluoro-6- O -trityl-β- d -glycero-hexopyranosyl-4-ulose)- N 4 -benzoyl cytosine ( 7a ), 1-(3,4-dideoxy-3-fluoro-6- O -trityl-β- d -glycero-hexopyranosyl-2-ulose)- N 4 -benzoyl cytosine ( 13a ) and their detritylated analogues 8a and 14a , respectively, is described. Condensation of peracetylated 3-deoxy-3-fluoro- d -glucopyranose ( 1 ) with silylated N 4 -benzoyl cytosine, followed by selective deprotection and isopropylidenation afforded compound 2 . Routine deoxygenation at position 2′, followed by a deprotection-selective reprotection sequence afforded the partially tritylated dideoxy nucleoside of cytosine 6 , which upon oxidation of the free hydroxyl group at the 4′-position, furnished the desired tritylated 2,3-dideoxy-3-fluoro ketonucleoside 7a in equilibrium with its hydrated form 7b . Compound 2 was the starting material for the synthesis of the dideoxy fluoro ketopyranonucleoside 13a . Similarly, several subsequent protection and deprotection steps as well as routine deoxygenation at position 4′, followed by oxidation of the free hydroxyl group at the 2′-position of the partially tritylated dideoxy nucleoside 12 , yielded the desired carbonyl compound 13a in equilibrium with its hydrated form 13b . Finally, trityl removal from 7a / b and 13a / b provided the unprotected 2,3-dideoxy-3-fluoro-4-keto and 3,4-dideoxy-3-fluoro-2-ketopyranonucleoside analogues 8a and 14a , in equilibrium with their gem-diol forms 8b and 14b . None of the compounds showed inhibitory activity against a wide variety of DNA and RNA viruses at subtoxic concentrations, except 7a / b that was highly efficient against rotavirus infection. Nucleoside 7a / b also exhibited cytostatic activity against cells of various cancers. BrdU-cell cycle analysis revealed that the mechanism of cytostatic activity may be related to a delay in G1/S phase and initiation of programmed cell death. A synthesis of the novel dideoxy fluoro ketopyranonucleoside analogues of N 4 -benzoyl cytosine ( 7a , 8a and 13a , 14a ) in equilibrium with their hydrated forms ( 7b , 8b and 13b , 14b ) is reported. 7a / b was highly efficient against rotavirus infection and exhibited high and selective antitumor activity against cells of various cancers as compared with other compounds, AZT or 5FU respectively. BrdU-cell cycle analysis revealed that the mechanism of antitumor activity may be related to a delay in G1/S phase and programmed cell death initiation.</abstract><cop>Kidlington</cop><pub>Elsevier</pub><pmid>19246130</pmid><doi>10.1016/j.ejmech.2009.01.020</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0223-5234
ispartof European journal of medicinal chemistry, 2009-06, Vol.44 (6), p.2696-2704
issn 0223-5234
1768-3254
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7126854
source Elsevier ScienceDirect Journals
subjects Antibiotics. Antiinfectious agents. Antiparasitic agents
Antineoplastic agents
Antiviral agents
Biological and medical sciences
General aspects
Medical sciences
Pharmacology. Drug treatments
Short Communication
title Dideoxy fluoro-ketopyranosyl nucleosides as potent antiviral agents: Synthesis and biological evaluation of 2,3- and 3,4-dideoxy-3-fluoro-4-and -2-keto-β-D-glucopyranosyl derivatives of N4-benzoyl cytosine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T09%3A40%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dideoxy%20fluoro-ketopyranosyl%20nucleosides%20as%20potent%20antiviral%20agents:%20Synthesis%20and%20biological%20evaluation%20of%202,3-%20and%203,4-dideoxy-3-fluoro-4-and%20-2-keto-%CE%B2-D-glucopyranosyl%20derivatives%20of%20N4-benzoyl%20cytosine&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=MANTA,%20Stella&rft.date=2009-06&rft.volume=44&rft.issue=6&rft.spage=2696&rft.epage=2704&rft.pages=2696-2704&rft.issn=0223-5234&rft.eissn=1768-3254&rft.coden=EJMCA5&rft_id=info:doi/10.1016/j.ejmech.2009.01.020&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_7126854%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19246130&rfr_iscdi=true